Airway Epithelial Cell Responses in Respiratory Inflammatory Conditions

The airway epithelium constitutes the first line of defence against inhaled pathogens, allergens and pollutants. Inflammatory conditions such as asthma, chronic obstructive pulmonary disease and cystic fibrosis provoke a cascade of epithelial responses that include barrier disruption, mucous cell metaplasia, altered ion transport and dysregulated repair processes. Epithelial cells sense environmental insults through pattern recognition receptors and rapidly secrete cytokines, chemokines and growth factors that orchestrate immune cell recruitment and activation. Dysregulated tight junctions and impaired ciliary function compromise mucociliary clearance, favouring persistent inflammation and tissue remodelling. Chronic exposure to type 2 cytokines drives goblet cell hyperplasia and excessive mucin production, while growth factor signalling via receptors such as the epidermal growth factor receptor promotes aberrant repair and fibrotic remodelling. Crosstalk between the epithelium and underlying mesenchyme further amplifies airway wall thickening and hyperresponsiveness. Understanding the molecular pathways by which epithelial cells detect, transduce and resolve inflammatory stimuli is crucial to devising therapies that restore barrier integrity, normal mucin secretion and balanced repair in chronic respiratory disease.

Research from Nature Portfolio

Recent studies have elucidated the central role of upstream kinase transactivation in coordinating inflammatory signalling within the epithelium. In murine models of allergic airway inflammation, blockade of Src kinase-mediated activation of the epidermal growth factor receptor was shown to attenuate downstream ERK1/2, PI3Kδ/Akt and NF-κB pathways, leading to reduced goblet cell hyperplasia, airway hyperresponsiveness and peribronchial inflammation. Complementary work in airway epithelial cell lines demonstrated that targeted modulation of the GABAergic system can suppress pathological mucus overproduction; a naturally occurring flavonoid was found to inhibit GABAA receptor-mediated currents, thereby limiting goblet cell expansion and mucin secretion in vivo. These findings underscore the therapeutic potential of broad upstream inhibition of receptor transactivation and non-canonical neurotransmitter pathways in limiting epithelial-driven inflammation.

Airway Epithelial Cell Responses in Respiratory Inflammatory Conditions publication trend

The graph below shows the total number of articles in airway epithelial cell responses in respiratory inflammatory conditions across all publications each year (not limited to Nature Index journals).

Technical terms

Goblet cell hyperplasia: An increase in the number of mucus-secreting cells within the airway lining, leading to excessive mucus production.

Mucociliary clearance: The coordinated movement of mucus by ciliary action to remove inhaled particles and pathogens from the airways.

Epidermal growth factor receptor (EGFR): A cell-surface tyrosine kinase receptor that regulates epithelial proliferation, differentiation and repair.

Tight junctions: Intercellular protein complexes that seal adjacent epithelial cells, maintaining barrier integrity and selective permeability.

Epithelial-mesenchymal transition (EMT): A process by which epithelial cells acquire mesenchymal characteristics, contributing to tissue remodelling and fibrosis.

Post-translational modification: Chemical alteration of proteins after synthesis, such as phosphorylation or ubiquitination, that modulates function and stability.

References

1. Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1/2, PI3Kδ/Akt and NFκB induction in a murine asthma model. Scientific Reports (2017).
2. Luteolin Attenuates Airway Mucus Overproduction via Inhibition of the GABAergic System. Scientific Reports (2016).
3. Amphiregulin induces CCN2 and fibronectin expression by TGF-β through EGFR-dependent pathway in lung epithelial cells. Respiratory Research (2022).
4. Pyocyanin-induced mucin production is associated with redox modification of FOXA2. Respiratory Research (2013).
5. Airway Epithelial Dysfunction in Asthma: Relevant to Epidermal Growth Factor Receptors and Airway Epithelial Cells. Journal of Clinical Medicine (2020).